ST诺泰(688076.SH)发布上半年业绩，归母净利润3.1亿元，增长36.49%

Core Viewpoint - ST Nuotai (688076.SH) reported a strong financial performance for the first half of 2025, with significant growth in both revenue and net profit, driven by increased sales of peptide raw materials [1] Financial Performance - The company's operating revenue reached 1.048 billion yuan, representing a year-on-year increase of 26.07% [1] - Net profit attributable to shareholders was 310 million yuan, reflecting a year-on-year growth of 36.49% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 306 million yuan, up 33.49% year-on-year [1] - Basic earnings per share stood at 0.99 yuan [1] Revenue Growth Drivers - The increase in operating revenue was primarily attributed to the growth in sales of peptide raw materials during the reporting period [1]